fluIds
Sepsis-induced tissue hypoperfusion defined as hypotension (mean arterial pressure [MAP] <65 mmHg) persisting after initial fluid challenge or blood lactate concentration ≥4 mmol/L (18 mg/dL) was managed with fluid resuscitation. The first 6-h goals of resuscitation included central venous pressure of 8-12 mmHg, MAP ≥65 mmHg, urine output ≥0.5 ml/kg/h, central or mixed venous oxygen saturation of 70% or 65%, respectively, and normalization of lactate. The initial fluid for resuscitation was crystalloids; albumin was used if substantial amount of crystalloid was required. Fluid challenge was guided by dynamic (e.g., pulse pressure or stroke volume variation) or static (e.g., arterial pressure, heart rate) variables.
VasoPressors and InotroPes
Noradrenaline was the vasopressor of choice to target MAP 65 mmHg. Vasopressin 0.04 units/min was added to improve the MAP, except in patients with acute coronary ischemia or preexisting coronary artery disease. Dobutamine infusion up to 15 µg/kg/min was tried in the presence of myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output or ongoing signs of hypoperfusion steroIds Continuous infusion of hydrocortisone 200 mg/day was used in septic shock when adequate fluid resuscitation and vasopressor therapy were unable to restore hemodynamic stability. This was tapered over 5-7 days, depending on the response.
Blood and Blood Product transfusIons
Red blood cell transfusion was administered when hemoglobin (Hb) decreased to <7 g/dL to target Hb of 7-9 g/dL. Higher Hb was targeted in patients with myocardial ischemia, severe hypoxemia, acute hemorrhage, or ischemic heart disease. Fresh frozen plasma and platelet transfusion were used only when a patient with deranged coagulation or low platelet count was bleeding or invasive procedures were planned. Platelets were prophylactically transfused with counts <10 × 10 9 /L antIMIcroBIals and source control Clinically appropriate cultures and imaging studies were performed before start of antimicrobial(s). At least two sets of blood cultures (both aerobic and anaerobic) were obtained before antimicrobial(s). Effective intravenous antimicrobials were aimed to be administered within the 1 st h of recognition of septic shock and severe sepsis. Initial empiric therapy with ≥1 anti-infective agents was selected based on activity against all likely pathogens (bacterial and/or fungal) and pharmacology. Combination empirical therapy was used for neutropenic patients with severe sepsis and for difficult-to-treat, multidrug-resistant (MDR) bacterial pathogens. Antimicrobial regimen was reassessed daily for potential de-escalation, aided by procalcitonin trends and susceptibility profile. Duration of therapy was typically 5-7 days. However, patients with slow clinical response, undrainable septic foci, MDR bacteremia, and some fungal infections or immunodeficiency, including neutropenia, received a longer course of antimicrobial(s). Emergent source control with least physiologic insult (e.g., percutaneous rather than surgical drainage of an abscess) was sought and undertaken as early as possible. An intravascular access device as a possible source of sepsis was removed promptly.
MechanIcal VentIlatIon
In patients on mechanical ventilation, target tidal volume of ≤6 mL/kg predicted body weight and plateau pressure of ≤30 cm H 2 O was aimed at in sepsis-induced acute respiratory distress syndrome (ARDS). Positive end-expiratory pressure (PEEP) was applied to avoid alveolar collapse. Higher rather than lower level of PEEP, recruitment maneuver, and/or prone positioning was used for patients with severe refractory hypoxemia. Head of bed was elevated to 30°-45° to decrease the risk of aspiration and subsequent ventilator-associated pneumonia. Spontaneous breathing trial (SBT) with pressure support ventilation or T-piece was administered regularly to attempt weaning as and when the patient was conscious, hemodynamically stable, low ventilatory and PEEP requirement, and low FiO 2 requirement which could be safely delivered with a face mask. Successful SBT resulted in consideration for extubation. Conservative rather than liberal fluid strategy was the norm in patients with established sepsis-induced ARDS.
renal rePlaceMent
Continuous renal replacement therapy was used for fluid management in hemodynamically unstable septic acute kidney injury patients with oligoanuria and/or refractory metabolic acidosis or hyperkalemia. Sustained low-efficiency dialysis was the preferred modality except when it was hemodynamically intolerable or continuous anticoagulation not desirable. Sodium bicarbonate was avoided.
suPPleMentary fIle sedatIon and ParalysIs
Continuous or intermittent sedation was titrated in mechanically ventilated sepsis patients, to a target Richmond Agitation-Sedation Score of 2 or higher. A short course of neuromuscular blocking agent (intermittent bolus or continuous infusion) not exceeding 48 h was used only for patients with early sepsis-induced ARDS and a PaO 2 /FiO 2 <150 mmHg.
Venous throMBoeMBolIsM and stress ulcer ProPhylaxIs
Patients received daily subcutaneous low-molecular-weight heparin and/or intermittent pneumatic compression against venous thromboembolism. Dalteparin was used if creatinine clearance was <30 ml/min. Stress ulcer prophylaxis using proton pump inhibitor was given to all patients with risk factors for bleeding.
nutrItIon and glyceMIc control
Enteral feeding was initiated in all patients as soon as the hemodynamics allowed. Low-dose feeding (e.g., up to 500 calories per day) was advanced as tolerated. Intravenous glucose and enteral nutrition was preferred to total parenteral nutrition (TPN) alone or in conjunction with enteral feeding. Prokinetics were initiated prophylactically. Continuous infusion feeds instead of bolus feeds were started if gastric residual volume was >50% of enteral intake. Feed intolerance with nasogastric feeds was managed with nasojejunal (NJ) feeds (NJ tube placed in radiology suite under fluoroscopy). A protocol for evaluation of safety, delivery, continuity, and success of enteral nutrition was in place for all patients. If this was also not tolerated, TPN was initiated. Euglycemia (target blood glucose 150-180 mg/dl) was maintained with continuous insulin infusion. 
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